Literature DB >> 34255814

A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication.

Yue Sheng1, Jiangbo Wei2,3, Fang Yu1, Huanzhou Xu4, Chunjie Yu1, Qiong Wu1, Yin Liu1, Lei Li5,6, Xiao-Long Cui2,3, Xueying Gu7, Bin Shen7, Wei Li5, Yong Huang8, Sumita Bhaduri-McIntosh4,9, Chuan He2,3, Zhijian Qian1.   

Abstract

YTHDC1 has distinct functions as a nuclear N6-methyladenosine (m6A) reader in regulating RNA metabolism. Here we show that YTHDC1 is overexpressed in acute myeloid leukemia (AML) and that it is required for the proliferation and survival of human AML cells. Genetic deletion of Ythdc1 markedly blocks AML development and maintenance as well as self-renewal of leukemia stem cells (LSCs) in vivo in mice. We found that Ythdc1 is also required for normal hematopoiesis and hematopoietic stem and progenitor cell (HSPC) maintenance in vivo. Notably, Ythdc1 haploinsufficiency reduces self-renewal of LSCs but not HSPCs in vivo. YTHDC1 knockdown has a strong inhibitory effect on proliferation of primary AML cells. Mechanistically, YTHDC1 regulates leukemogenesis through MCM4, which is a critical regulator of DNA replication. Our study provides compelling evidence that shows an oncogenic role and a distinct mechanism of YTHDC1 in AML.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34255814      PMCID: PMC8718631          DOI: 10.1182/blood.2021011707

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

Review 1.  MCM proteins in DNA replication.

Authors:  B K Tye
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 2.  Regulation of MCM2-7 function.

Authors:  Yukio Ishimi
Journal:  Genes Genet Syst       Date:  2018-10-23       Impact factor: 1.517

3.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

4.  Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos.

Authors:  Chuan Chen; Wenqiang Liu; Jiayin Guo; Yuanyuan Liu; Xuelian Liu; Jun Liu; Xiaoyang Dou; Rongrong Le; Yixin Huang; Chong Li; Lingyue Yang; Xiaochen Kou; Yanhong Zhao; You Wu; Jiayu Chen; Hong Wang; Bin Shen; Yawei Gao; Shaorong Gao
Journal:  Protein Cell       Date:  2021-04-22       Impact factor: 14.870

5.  METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification.

Authors:  Hengyou Weng; Huilin Huang; Huizhe Wu; Xi Qin; Boxuan Simen Zhao; Lei Dong; Hailing Shi; Jennifer Skibbe; Chao Shen; Chao Hu; Yue Sheng; Yungui Wang; Mark Wunderlich; Bin Zhang; Louis C Dore; Rui Su; Xiaolan Deng; Kyle Ferchen; Chenying Li; Miao Sun; Zhike Lu; Xi Jiang; Guido Marcucci; James C Mulloy; Jianhua Yang; Zhijian Qian; Minjie Wei; Chuan He; Jianjun Chen
Journal:  Cell Stem Cell       Date:  2017-12-28       Impact factor: 25.269

6.  The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells.

Authors:  Yu Hou; Wen Li; Yue Sheng; Liping Li; Yong Huang; Zhonghui Zhang; Tongyu Zhu; David Peace; John G Quigley; Wenshu Wu; You-Yang Zhao; Zhijian Qian
Journal:  Nat Immunol       Date:  2015-06-29       Impact factor: 25.606

7.  YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex.

Authors:  Hao Du; Ya Zhao; Jinqiu He; Yao Zhang; Hairui Xi; Mofang Liu; Jinbiao Ma; Ligang Wu
Journal:  Nat Commun       Date:  2016-08-25       Impact factor: 14.919

8.  Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation.

Authors:  Heather Lee; Suying Bao; Yingzhi Qian; Shay Geula; Juliana Leslie; Chaolin Zhang; Jacob H Hanna; Lei Ding
Journal:  Nat Cell Biol       Date:  2019-05-06       Impact factor: 28.824

9.  Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.

Authors:  Jasmin Paris; Marcos Morgan; Joana Campos; Gary J Spencer; Alena Shmakova; Ivayla Ivanova; Christopher Mapperley; Hannah Lawson; David A Wotherspoon; Catarina Sepulveda; Milica Vukovic; Lewis Allen; Annika Sarapuu; Andrea Tavosanis; Amelie V Guitart; Arnaud Villacreces; Christian Much; Junho Choe; Ali Azar; Louie N van de Lagemaat; Douglas Vernimmen; Ali Nehme; Frederic Mazurier; Tim C P Somervaille; Richard I Gregory; Dónal O'Carroll; Kamil R Kranc
Journal:  Cell Stem Cell       Date:  2019-04-25       Impact factor: 24.633

View more
  17 in total

1.  Ticket to divide: m6A reader YTHDC1 drives acute myeloid leukemia proliferation.

Authors:  Andrew Volk
Journal:  Blood       Date:  2021-12-30       Impact factor: 22.113

Review 2.  One Stone, Two Birds: N6-Methyladenosine RNA Modification in Leukemia Stem Cells and the Tumor Immune Microenvironment in Acute Myeloid Leukemia.

Authors:  Xianfeng Ouyang; Yuping Gong
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 3.  RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness.

Authors:  Huarong Chen; Yifei Wang; Hao Su; Xiaoting Zhang; Hongyan Chen; Jun Yu
Journal:  Front Cell Dev Biol       Date:  2022-07-04

4.  Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis.

Authors:  Qiaoling Xiao; Li Lei; Jun Ren; Meixi Peng; Yipei Jing; Xueke Jiang; Junpeng Huang; Yonghong Tao; Can Lin; Jing Yang; Minghui Sun; Lisha Tang; Xingyu Wei; Zailin Yang; Ling Zhang
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

Review 5.  Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases.

Authors:  Huaqing Yan; Liqi Zhang; Xiaobo Cui; Sinian Zheng; Rubing Li
Journal:  Cell Death Discov       Date:  2022-05-02

Review 6.  The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance.

Authors:  Zhaolin Chen; Ying Hu; Le Jin; Fan Yang; Haiwen Ding; Lei Zhang; Lili Li; Tingting Pan
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

Review 7.  The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.

Authors:  Na Song; Kai Cui; Ke Zhang; Jie Yang; Jia Liu; Zhuang Miao; Feiyue Zhao; Hongjing Meng; Lu Chen; Chong Chen; Yushan Li; Minglong Shao; Jinghang Zhang; Haijun Wang
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

8.  m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.

Authors:  Zi-Jun Xu; Xiang-Mei Wen; Yuan-Cui Zhang; Ye Jin; Ji-Chun Ma; Yu Gu; Xin-Yi Chen; Pei-Hui Xia; Wei Qian; Jiang Lin; Jun Qian
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

9.  Decoding m6A, one reader at a time.

Authors:  Hanzhi Luo; Michael G Kharas
Journal:  Haematologica       Date:  2022-08-01       Impact factor: 11.047

Review 10.  The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies.

Authors:  Yan Zhao; Hongling Peng
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.